(redirected from Blood substitutes)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.

BLOOD, kindred. This word, in the law sense, is used to signify relationship, stock, or family; as, of the blood of the ancestor. 1 Roper on Leg. 103; 1 Supp. to Ves. jr. 365. In a more extended sense, it means kindred generally. Bac. Max. Reg. 18.
     2. Brothers and sisters are said to be of the whole blood, (q. v.) if they have the same father and mother of the half blood, (q. v.) if they have only one parent in common. 5 Whart. Rep. 477.

A Law Dictionary, Adapted to the Constitution and Laws of the United States. By John Bouvier. Published 1856.
References in periodicals archive ?
The presence of a large patient pool with intraoperative complications is one of the key factors contributing to the growth of the artificial blood substitutes market.
Uncontrolled hypertension Table 3: The possible advantages of blood substitutes over human blood Advantages 1.
Chapter 3 provides an overview of the leading blood substitutes deals since 2009.
Innovative approaches to developing a potential blood substitute involves expertise in any combination of biotechnology, physiology, biophysics, biochemistry, chemical engineering, enzyme engineering, biomedical engineering, genetic engineering, clinical medicine, chemistry, and polymer chemistry.
However, the study protocol allows PolyHeme to be given for up to 12 hours after arrival at the hospital in those patients who received the blood substitute during the ambulance ride.
This blood substitute can be produced in large quantities and stored for two years at 41[degrees]F, and for more than four months at 86[degrees]F, compared to 40 days at 39[degrees]F for natural blood.
Have scientists created any blood substitutes to help prevent a shortage?
Petersburg, Fla., will discuss its experiments with perfluorinated hydrocarbons--compounds mainly used as synthetic blood substitutes and soldering fluids--as additives to rigid urethane and isocyanurate insulating foams.
2 April 2013 - Russian diversified holding company Sistema JSFC (LON:SSA) said on Tuesday pharmaceutical unit CJSC Binnopharm had combined its assets with infusion solutions and blood substitutes specialist Alium Group of Companies.
However, Prof Tsai said the need for blood substitutes would increase as the population ages.